Valeant Pharmaceuticals Inc may take its $49.44 billion takeover bid for Botox-maker Allergan Inc directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday. Pearson, speaking to investors of both companies in New York City, also said Valeant will not keep increasing its offer until it meets with the Allergan board.
Allergan, Inc. is a multi-specialty health care Company focused on developing and commercializing pharmaceuticals, biologics, medical devices and over-the-counter products. Shares of AGN fell by 4.06% or $-6.7/share to $158.32. In the past year, the shares have traded as low as $81.33 and as high as $170.05. On average, 4210130 shares of AGN exchange hands on a given day and today's volume is recorded at 6799711.
Source
